REMICADE (Janssen Biotech, Inc.)
Welcome to the PulseAid listing for the REMICADE drug offered from Janssen Biotech, Inc.. This Tumor Necrosis Factor Blocker [EPC],Tumor Necrosis Factor Receptor Blocking Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Janssen Biotech, Inc. |
| NON-PROPRIETARY NAME: | INFLIXIMAB |
| SUBSTANCE NAME: | INFLIXIMAB, LICENSE HOLDER UNSPECIFIED |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Tumor Necrosis Factor Blocker [EPC],Tumor Necrosis Factor Receptor Blocking Activity [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 1998-08-24 |
| END MARKETING DATE: | 0000-00-00 |
REMICADE HUMAN PRESCRIPTION DRUG Details:
| Item Description | REMICADE from Janssen Biotech, Inc. |
| LABELER NAME: | Janssen Biotech, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 100(mg/10mL) |
| START MARKETING DATE: | 1998-08-24 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 57894-030_dd84d623-c0c3-4783-9f5e-3b71c818bfd3 |
| PRODUCT NDC: | 57894-030 |
| APPLICATION NUMBER: | BLA103772 |
Other INFLIXIMAB, LICENSE HOLDER UNSPECIFIED Pharmaceutical Manufacturers / Labelers:
